Fatty acid metabolism related gene MECR contributes to the progression of prostate cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The MECR gene, involved in fatty acid metabolism, is crucial in prostate cancer (PCa) progression. Its expression impacts survival, prognosis, and the tumor immune microenvironment, offering potential therapeutic targets.
Area Of Science
- Oncology
- Molecular Biology
- Metabolism
Background
- Prostate cancer (PCa) is a heterogeneous malignancy with variable prognosis.
- Fatty acid metabolism is increasingly recognized for its role in tumor development.
Purpose Of The Study
- To investigate the role of the MECR gene in prostate cancer (PCa) development and progression.
- To explore the association of MECR with clinical features, survival, and the tumor immune microenvironment.
Main Methods
- Analysis of gene expression profiles from PCa cell lines (GSE6919).
- Assessment of overall survival and clinicopathological features using R package.
- Investigation of gene mutations, methylation, and immune cell infiltration via cBioPortal, UALCAN, and TIMER.
- In vitro and in vivo assays to evaluate MECR's impact on PCa cell behavior.
Main Results
- MECR expression is significantly associated with PCa clinical features, survival outcomes, and prognosis.
- MECR mutations and methylation levels correlate with prostate cancer progression.
- MECR influences the tumor immune microenvironment and immune cell infiltration.
- MECR promotes PCa cell proliferation, migration, and invasion.
Conclusions
- MECR is a key player in prostate cancer progression.
- MECR holds potential for prognostic assessment and immune microenvironment regulation in PCa.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...